Skip to main content
Clinical Trials/NCT04709341
NCT04709341CompletedNot Applicable

Optimization of Transradial-Band Removal Following Transradial Arterial Access for Interventional Radiology Diagnostic and Interventional Procedures (A Pilot Study)

Medical University of South Carolina2 sites in 1 country30 target enrollmentStarted: February 3, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
2
Primary Endpoint
Percentage of Participants With Bleeding

Study Overview

Brief Summary

In the study group, the TR-Band will be in left in place for 15 minutes before it is gradually deflated by 25% at 15 minute intervals. In the standard of care group, the TR-Band is left in place for 60 minutes before it is gradually deflated by 25% at 15 minute intervals. The aim of the study is to reduce the time the device is in place while minimizing potential complications.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years and older
  • Have an acceptable Barbeau test (i.e. type A through C)
  • Have acceptable coagulation parameters (based on PT, INR, platelet count, and appropriate pre-procedural management of anticoagulants, See Table 1)
  • The caliber of the left radial artery based on a pre-procedure sonographic evaluation will need to be greater than or equal to 1.6 mm.
  • The appropriate pre-procedural management of anticoagulants is based on the consensus guidelines established by Patel et al
  • INR less than 1.5
  • Platelet count greater than 50,000 platelet/uL
  • Prothrombin time less than 15 seconds

Exclusion Criteria

  • If there is an unacceptable risk of bleeding diathesis, or
  • If he or she is not a suitable candidate for transradial access based on a Barbeau test type D or a diameter of the left radial artery less than 1.6 mm.

Outcomes

Primary Outcomes

Percentage of Participants With Bleeding

Time Frame: 30 days post procedure

Continued ooze requiring re-inflation of the TR-Band or subcutaneous ecchymosis without a discernable hematoma

Left Radial Artery Occlusion

Time Frame: 30 days post procedure

Reduced or absence of radial artery blood flow based on ultrasound and Barbeau test

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Transradial-Band Pilot Study | Clinical Trial